With metformin being a glucose lowering agent for T2DM, we initially assessed blood glucose levels in P14 non-fasted, untreated, 200- and 400-mg/kg/day metformin treated Smn2B/− SMA and Smn2B/+ healthy mice 2 h after the final treatment. This evidence concerns the gene SMN1 and type 2 diabetes mellitus.